Identification of impurities in nafamostat mesylate using HPLC-IT-TOF/MS: A series of double-charged ions
Nafamostat mesylate is a serine protease inhibitor used in the treatment of acute pancreatitis. The impurities in nafamostat mesylate, the active pharmaceutical ingredient (API), were profiled via high performance liquid chromatography tandem ion trap coupled with time-of-flight mass spectrometer (H...
Saved in:
Main Authors: | Yuxin Zhang (Author), Lufan An (Author), Lin Zhang (Author), Rulin Wang (Author), Yuan Tian (Author), Zunjian Zhang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of processing on the alkaloids in Aconitum tubers by HPLC-TOF/MS
by: Min Liu, et al.
Published: (2017) -
Anticoagulation application of nafamostat mesylate in patients on continuous renal replacement therapy at a high risk of hemorrhage
by: Jia-rong Ding, et al.
Published: (2024) -
Development of Nafamostat Mesylate Immediate-Release Tablet by Drug Repositioning Using Quality-by-Design Approach
by: Hyeon-A Kim, et al.
Published: (2022) -
Separation and determination of acetyl-glutamine enantiomers by HPLC-MS and its application in pharmacokinetic study
by: Xiaoxiao Zhang, et al.
Published: (2017) -
Integration of transcriptomics and metabolomics reveals the molecular mechanisms underlying the effect of nafamostat mesylate on rhabdomyolysis-induced acute kidney injury
by: Wenli Guo, et al.
Published: (2022)